Financials data is unavailable for this security.
View more
Year on year Changmao Biochemical Engineering Co Ltd 's revenues fell -12.73% from 730.03m to 637.08m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a gain of 81.42m to a loss of 86.06m.
| Gross margin | 0.05% |
|---|---|
| Net profit margin | -16.66% |
| Operating margin | -11.51% |
| Return on assets | -8.56% |
|---|---|
| Return on equity | -15.86% |
| Return on investment | -12.16% |
More ▼
Cash flow in CNYView more
In 2023, Changmao Biochemical Engineering Co Ltd increased its cash reserves by 49.27%, or 29.56m. Cash Flow from Financing totalled 153.84m or 24.15% of revenues. In addition the company used 2.35m for operations while cash used for investing totalled 122.11m.
| Cash flow per share | -0.1369 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 1.29 |
|---|---|
| Tangible book value per share | 1.28 |
More ▼
Balance sheet in CNYView more
| Current ratio | 0.8662 |
|---|---|
| Quick ratio | 0.4914 |
| Total debt/total equity | 0.8446 |
|---|---|
| Total debt/total capital | 0.4578 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -100.00% and -205.69%, respectively.
| Div yield(5 year avg) | 5.08% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -343.84 |
More ▼
